HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides.

Abstract
Human topoisomerase II (topo II) is the cellular target for a number of widely used antitumor agents, such as etoposide (VP16). These agents 'poison' the enzyme and induce it to generate DNA breaks that are lethal to the cell. Topo II-targeted drugs show a limited sequence preference, triggering double-stranded breaks throughout the genome. Circumstantial evidence strongly suggests that some of these breaks induce chromosomal translocations that lead to specific types of leukaemia (called treatment-related or secondary leukaemia). Therefore, efforts are ongoing to decrease these secondary effects. An interesting option is to increase the sequence-specificity of topo II-targeted drugs by attaching them to triplex-forming oligonucleotides (TFO) that bind to DNA in a highly sequence-specific manner. Here five derivatives of VP16 were attached to TFOs. The active topo II poisons, once linked, induced cleavage 13-14 bp from the triplex end where the drug was attached. The use of triple-helical DNA structures offers an efficient strategy for targeting topo II-mediated cleavage to DNA specific sequences. Finally, drug-TFO conjugates are useful tools to investigate the mechanistic details of topo II poisoning.
AuthorsMaria Duca, Dominique Guianvarc'h, Kahina Oussedik, Ludovic Halby, Anna Garbesi, Daniel Dauzonne, Claude Monneret, Neil Osheroff, Carine Giovannangeli, Paola B Arimondo
JournalNucleic acids research (Nucleic Acids Res) Vol. 34 Issue 6 Pg. 1900-11 ( 2006) ISSN: 1362-4962 [Electronic] England
PMID16598074 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Enzyme Inhibitors
  • Oligodeoxyribonucleotides
  • Topoisomerase II Inhibitors
  • triplex DNA
  • Etoposide
  • DNA
  • DNA Topoisomerases, Type II
Topics
  • Antineoplastic Agents, Phytogenic (chemistry, toxicity)
  • DNA (chemistry)
  • DNA Damage
  • DNA Footprinting
  • DNA Topoisomerases, Type II (metabolism)
  • Drug Delivery Systems
  • Enzyme Inhibitors (chemistry, toxicity)
  • Etoposide (analogs & derivatives, toxicity)
  • Humans
  • Oligodeoxyribonucleotides (chemistry)
  • Topoisomerase II Inhibitors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: